Don't Be Alarmed if a Low Anticoagulant Dose is Used to Prevent Recurrent Clots

June 2017

More patients will use LOW-dose direct oral anticoagulants (DOACs) long-term to prevent recurrent venous thromboembolism (VTE).

Patients who have a VTE are typically treated with warfarin or a DOAC (Eliquis, etc) for 3 months.

This is usually long enough if an initial VTE was caused by a short-term risk...such as a minor trauma or surgery.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote